Alx Oncology Holdings
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 90.9% | 90.9% | 90.9% | 90.9% | 91.0% | 90.9% | – | 91.5% | – | – | – | – | – | – | – | – | – | – | – | 8.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 9.1% | 9.1% | 9.1% | 9.1% | 9.0% | 9.1% | – | 9.3% | – | – | – | – | – | – | – | – | – | – | – | -8.3% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| 361.7% | 280.2% | 176.0% | 555.2% | 584.4% | 1,454.1% | – | 1,028,983,050.8% | – | – | – | – | – | – | – | – | – | – | – | 1,684.8% | – | – | – | 2,711.1% | – | – | – | – | – | – | – | |
| 57.0% | 52.4% | 74.7% | 91.3% | 224.9% | 601.9% | – | 481,610,169.5% | – | – | – | – | – | – | – | – | – | – | – | 251.6% | – | – | – | 815.8% | – | – | – | – | – | – | – | |
| 418.7% | 332.6% | 250.6% | 646.6% | 809.3% | 2,056.0% | – | 1,510,593,220.3% | – | – | – | – | – | – | – | – | – | – | – | 1,936.4% | – | – | – | 3,526.8% | – | – | – | – | – | – | – | |
| -409.6% | -323.5% | -241.6% | -637.5% | -800.3% | -2,046.9% | – | -1,510,593,220.3% | – | – | – | – | – | – | – | – | – | – | – | -1,936.4% | – | – | – | -3,526.8% | – | – | – | – | – | – | – | |
| – | 0.0% | 0.0% | 1.7% | 32.8% | 41.6% | – | 12,796,610.2% | – | – | – | – | – | – | – | – | – | – | – | 16.7% | – | – | – | 49.2% | – | – | – | – | – | – | – | |
| -409.8% | -323.5% | -241.7% | -639.3% | -832.1% | -2,146.3% | – | -1,575,593,220.3% | – | – | – | – | – | – | – | – | – | – | – | -1,833.5% | – | – | – | -3,359.8% | – | – | – | – | – | – | – | |
| 0.9% | 0.6% | 0.6% | 0.7% | 0.6% | 3.8% | – | 15,423,728.8% | – | – | – | – | – | – | – | – | – | – | – | 46.2% | – | – | – | – | – | – | – | – | – | – | – | |
| -410.7% | -324.1% | -242.4% | -640.1% | -832.7% | -2,150.1% | – | -1,591,016,949.2% | – | – | – | – | – | – | – | – | – | – | – | -1,833.5% | – | – | – | -3,359.8% | – | – | – | – | – | – | – | |
| -400.4% | -315.1% | -232.9% | -628.4% | -782.0% | -2,089.8% | – | -1,562,372,881.4% | – | – | – | – | – | – | – | – | – | – | – | -1,808.5% | – | – | – | -3,285.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.